AU2003273035A1 - Gene vaccine - Google Patents

Gene vaccine

Info

Publication number: AU2003273035A1
Authority: AU; Australia
Prior art keywords: gene vaccine; vaccine; gene
Prior art date: 2002-10-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003273035A

Inventor

Masutaka Furue

Kunihiro Himeno

Yoshihiko Maehara

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kyushu TLO Co Ltd

Original Assignee

Kyushu TLO Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-17

Filing date

2003-10-16

Publication date

2004-05-04

2003-10-16 Application filed by Kyushu TLO Co Ltd filed Critical Kyushu TLO Co Ltd

2004-05-04 Publication of AU2003273035A1 publication Critical patent/AU2003273035A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AU2003273035A 2002-10-17 2003-10-16 Gene vaccine Abandoned AU2003273035A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002-302816		2002-10-17
JP2002302816A JP2006096663A (en)	2002-10-17	2002-10-17	Cancer gene vaccine
PCT/JP2003/013279 WO2004035085A1 (en)	2002-10-17	2003-10-16	Gene vaccine

Publications (1)

Publication Number	Publication Date
AU2003273035A1 true AU2003273035A1 (en)	2004-05-04

Family

ID=32105054

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003273035A Abandoned AU2003273035A1 (en)	2002-10-17	2003-10-16	Gene vaccine

Country Status (3)

Country	Link
JP (1)	JP2006096663A (en)
AU (1)	AU2003273035A1 (en)
WO (1)	WO2004035085A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2624879T3 (en)	2007-09-18	2017-07-17	Green Peptide Co., Ltd.	CTL inducing composition
MX2014010943A (en) *	2012-03-16	2014-11-26	Genentech Inc	Engineered conformationally-stabilized proteins.
US9139863B2 (en)	2012-03-16	2015-09-22	Genentech, Inc.	Engineered conformationally-stabilized proteins
JPWO2023068328A1 (en) *	2021-10-20	2023-04-27
CN113842399B (en) *	2021-10-28	2024-05-14	闽江学院	Marine protozoan servant extract with anti-tumor activity
WO2024063788A1 (en) *	2022-09-23	2024-03-28	BioNTech SE	Compositions for delivery of malaria antigens and related methods
WO2025064850A1 (en) *	2023-09-22	2025-03-27	BioNTech SE	Rna constructs with n-terminal degrons to enhance an immune response

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4431401A1 (en) *	1994-08-24	1996-02-29	Max Delbrueck Centrum	Live vaccine against tumor diseases

2002
- 2002-10-17 JP JP2002302816A patent/JP2006096663A/en active Pending
2003
- 2003-10-16 AU AU2003273035A patent/AU2003273035A1/en not_active Abandoned
- 2003-10-16 WO PCT/JP2003/013279 patent/WO2004035085A1/en not_active Ceased

Also Published As

Publication number	Publication date
JP2006096663A (en)	2006-04-13
WO2004035085A1 (en)	2004-04-29

Publication	Publication Date	Title
AU2003218483A1 (en)	2003-10-20	Novel expressed genes
AU2002313559A1 (en)	2003-03-10	Genes
AU2003301850A1 (en)	2004-06-07	Hiv vaccine
AU2003285320A1 (en)	2004-06-07	Vaccine
AU2003289603A1 (en)	2004-07-09	Tumor vaccine
AU2003228139A1 (en)	2003-11-17	Bioreactor
AU2003228708A1 (en)	2003-11-10	Elongated member lifting system
AU2003273035A1 (en)	2004-05-04	Gene vaccine
AU2003237701A1 (en)	2003-12-12	Vaccines
AU2003294705A1 (en)	2004-06-07	NtSM GENE
AUPS084502A0 (en)	2002-03-28	Anti-protozoal vaccine
AU2002347346A1 (en)	2003-06-17	Dna vaccine
AU2003267384A1 (en)	2004-04-19	Bhyd gene
AU2003229503A1 (en)	2003-11-10	Genetic vaccine against rna-viral infections
AU2003241762A1 (en)	2004-02-25	Dna shuflling
AU2002331950A1 (en)	2004-04-08	Vaccine
HK1069405A (en)	2005-05-20	Height-related gene
AUPS086102A0 (en)	2002-03-28	Vaccine iii
AU2002328863A1 (en)	2003-01-29	Oncosuppressive gene
AU2003241946A1 (en)	2003-12-22	Novel acylase gene
AU2003252991A1 (en)	2004-02-25	INTERFERON-Alpha INDUCED GENE
AU2003220853A1 (en)	2003-10-13	Abc transporter-associated gene abcc13
HK1074222A (en)	2005-11-04	Marker gene
AU2002337325A1 (en)	2003-05-12	Gene expression
AU2002319485A1 (en)	2003-02-17	Dna vaccine

Legal Events

Date	Code	Title	Description
2005-07-14	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase